CN121218983A - 含有米洛巴林的医药组合物 - Google Patents

含有米洛巴林的医药组合物

Info

Publication number
CN121218983A
CN121218983A CN202480035836.7A CN202480035836A CN121218983A CN 121218983 A CN121218983 A CN 121218983A CN 202480035836 A CN202480035836 A CN 202480035836A CN 121218983 A CN121218983 A CN 121218983A
Authority
CN
China
Prior art keywords
dosage form
solid dosage
pharmaceutically acceptable
milobalin
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480035836.7A
Other languages
English (en)
Chinese (zh)
Inventor
宫野友纪
小林谦吾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of CN121218983A publication Critical patent/CN121218983A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
CN202480035836.7A 2023-06-02 2024-05-30 含有米洛巴林的医药组合物 Pending CN121218983A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-091991 2023-06-02
JP2023091991 2023-06-02
PCT/JP2024/019828 WO2024248079A1 (ja) 2023-06-02 2024-05-30 ミロガバリンを含有する医薬組成物

Publications (1)

Publication Number Publication Date
CN121218983A true CN121218983A (zh) 2025-12-26

Family

ID=93658131

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480035836.7A Pending CN121218983A (zh) 2023-06-02 2024-05-30 含有米洛巴林的医药组合物

Country Status (5)

Country Link
JP (1) JPWO2024248079A1 (https=)
KR (1) KR20260018020A (https=)
CN (1) CN121218983A (https=)
TW (1) TW202513048A (https=)
WO (1) WO2024248079A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121221543A (zh) * 2025-11-26 2025-12-30 华润双鹤利民药业（济南）有限公司 一种苯磺酸美洛加巴林口崩片制剂及其制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119732941B (zh) * 2024-12-30 2026-04-28 上海博悦生物科技有限公司 含有苯磺酸美洛加巴林的药物组合物及其制备方法
CN120531691B (zh) * 2025-06-20 2026-04-28 苏州美诺医药科技有限公司 一种苯磺酸美洛加巴林固体药物组合物、制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2657219B1 (en) 2007-09-28 2014-12-10 Daiichi Sankyo Company, Limited Intermediate for producing bicyclic y-amino acid derivative
CN104334169B (zh) 2013-04-04 2016-11-02 第一三共株式会社 包含氨基羧酸盐的固体组合物
BR112017019918B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
BR112021001008A2 (pt) 2018-07-30 2021-04-20 Daiichi Sankyo Company, Limited comprimido de fármaco
ES3025936T3 (en) * 2019-12-23 2025-06-10 Daiichi Sankyo Co Ltd Film-coated tablets having smooth surface
CN115803020A (zh) * 2020-07-27 2023-03-14 第一三共株式会社 含有苯磺酸米洛巴林的口腔崩解片剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121221543A (zh) * 2025-11-26 2025-12-30 华润双鹤利民药业（济南）有限公司 一种苯磺酸美洛加巴林口崩片制剂及其制备方法

Also Published As

Publication number Publication date
WO2024248079A1 (ja) 2024-12-05
JPWO2024248079A1 (https=) 2024-12-05
KR20260018020A (ko) 2026-02-06
TW202513048A (zh) 2025-04-01

Similar Documents

Publication Publication Date Title
CN121218983A (zh) 含有米洛巴林的医药组合物
KR102684756B1 (ko) 엔잘루타미드를 함유하는 경구 투여용 의약 조성물
TWI428151B (zh) 含有甘露醇或乳糖之固形製劑
ES2354030T3 (es) Preparación farmacéutica sólida que comprende benzacepinas, y procedimiento de producción de la misma.
US10583087B2 (en) Pharmaceutical composition for oral administration
TW201717937A (zh) 含有芳基烷基胺化合物之醫藥組合物
JP2016104812A (ja) ロキソプロフェンナトリウム及びトラネキサム酸を含有する固形製剤
JP7322475B2 (ja) アジルサルタンを含有する錠剤
JP2023036924A (ja) レナリドミドを含む医薬組成物
TW202011950A (zh) 含安定劑之醫藥品的固體製劑
WO2010001930A1 (ja) 固形内服製剤
JP7322474B2 (ja) アジルサルタンを含有する錠剤
CN110494139B (zh) 含有纳呋拉啡的经片剂化的药物组合物
US9775832B2 (en) Pharmaceutical composition for oral administration
JP7206872B2 (ja) アジルサルタン及びアムロジピンを含有する医薬組成物及びその製造方法
HK40129253A (zh) 含有米洛巴林的医药组合物
US20190282569A1 (en) Stable pharmaceutical composition
TW201808290A (zh) 經光穩定性提升之固體製劑
JPWO2007046411A1 (ja) イソキサゾール化合物の安定化方法
TWI746418B (zh) 包含1-[6-(嗎啉-4-基)嘧啶-4-基]-4-(1h-1,2,3-三唑-1-基)-1h-吡唑-5-醇鈉之醫藥劑型
JP4696210B2 (ja) イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JP6112765B2 (ja) ロキソプロフェンナトリウム及びｄｌ−メチルエフェドリン塩酸塩を含有する固形製剤
TW202333702A (zh) 具有優異溶出性之醫藥組成物
WO2025170558A1 (en) A solid oral pharmaceutical formulation comprising avatrombopag
EP4599824A1 (en) A solid oral pharmaceutical formulation comprising avatrombopag

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40129253

Country of ref document: HK